Subjects who have developed SARS-CoV-2 specific IgM-S after vaccination show a longer humoral immunity and a lower frequency of infection
| العنوان: | Subjects who have developed SARS-CoV-2 specific IgM-S after vaccination show a longer humoral immunity and a lower frequency of infection |
|---|---|
| المؤلفون: | Piubelli, Chiara, Ruggiero, Alessandra, Calciano, Lucia, Mazzi, Cristina, Castilletti, Concetta, Tiberti, Natalia, Caldrer, Sara, Verzè, Matteo, Longoni, Silvia Stefania, Accordini, Simone, Bisoffi, Zeno, Zipeto, Donato |
| سنة النشر: | 2022 |
| المجموعة: | Zenodo |
| مصطلحات موضوعية: | SARS-CoV-2, BTN162b2 vaccine, IgG, IgM, breakthrough infection |
| الوصف: | We analysed anti-SARS-CoV-2 spike (S) protein (IgG-S), anti-nucleocapsid IgG (IgG-N) and anti-Spike IgM (IgM-S) in 1872 vaccinees at the first dose (D1; w0), after three weeks at the second dose (D2; w3) at three (w6) and 23 weeks (w29) after D2; 109 subjects where further tested at the booster dose (D3, w44), at three weeks (w47) and six months (w70) after D3. Two-level linear regression models were used to evaluate the differences in IgG-S levels. |
| نوع الوثيقة: | dataset |
| اللغة: | unknown |
| العلاقة: | https://zenodo.org/record/7158961Test; https://doi.org/10.5281/zenodo.7158961Test; oai:zenodo.org:7158961 |
| DOI: | 10.5281/zenodo.7158961 |
| الإتاحة: | https://doi.org/10.5281/zenodo.7158961Test https://doi.org/10.5281/zenodo.7158960Test https://zenodo.org/record/7158961Test |
| حقوق: | info:eu-repo/semantics/restrictedAccess |
| رقم الانضمام: | edsbas.5D97E63E |
| قاعدة البيانات: | BASE |
| DOI: | 10.5281/zenodo.7158961 |
|---|